Paul Yann Lin

Dr. Paul Yann Lin


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jrhau LungJrhau Lung
Jrhau Lung
MHMing-Szu Hung
Ming-Szu Hung
TWTing-Yao Wang
Ting-Yao Wang
KCKuan-Liang Chen
Kuan-Liang Chen
CLChi-Wen Luo
Chi-Wen Luo
YLYu-Ching Lin
Yu-Ching Lin
For rapid and unlimited cell growth and proliferation, cancer cells require large quantities of nutrients. Many metabolic pathways and nutrient uptake systems are frequently reprogrammed and upregulated to meet the demand from cancer cells, including the demand for lipids. The lipids for most adult normal cells are mainly acquired from the circulatory system. Whether different cancer cells adopt identical mechanisms to ensure sufficient lipid supply, and whether the lipid demand and supply meet each other, remains unclear, and was investigated in lung cancer cells. Results showed that, despite frequent upregulation in de novo lipogenesis and the lipid transporter system, different lung cancer cells adopt different proteins to acquire sufficient lipids, and the lipid supply frequently exceeds the demand, as significant amounts of lipids stored in the lipid droplets could be found within lung cancer cells. Lipid droplet surface protein, PLIN3, was found frequently overexpressed since the early stage in lung cancer tissues. Although the expression is not significantly associated with a specific gender, age, histology type, disease stage, and smoking habit, the frequently elevated expression of PLIN3 protein indicates the importance of lipid droplets for lung cancer. These lipid droplets are not only for nutrient storage, but are also crucial for tumor growth and proliferation, as well as survival in starvation. These results suggest that manipulation of lipid droplet formation or TG storage in lung cancer cells could potentially decrease the progression of lung cancer. Further exploration of lipid biology in lung cancer could help design novel treatment strategies.

2 May 2019 in Cancers
Verified
Journal Article
Open access
PDF file
MHMing-Szu Hung
Ming-Szu Hung
YCYi-Chuan Chen
Yi-Chuan Chen
PLPaul Yann Lin
Paul Yann Lin
YLYa-Chin Li
Ya-Chin Li
CHChia-Chen Hsu
Chia-Chen Hsu
CYCheng-Ta Yang
Cheng-Ta Yang
Cullin 4A (Cul4A) is overexpressed in a number of cancers and has been established as an oncogene. This study aimed to elucidate the role of Cul4A in lung cancer invasion and metastasis. We observed that Cul4A was overexpressed in non-small cell lung cancer (NSCLC) tissues and the overexpression of Cul4A was associated with poor prognosis after surgical resection and it also decreased the expression of the tumor suppressor protein annexin A10 (ANXA10). The knockdown of Cul4A was associated with the upregulation of ANXA10, and the forced expression of Cul4A was associated with the downregulation of ANXA10 in lung cancer cells. Further studies showed that the knockdown of Cul4A inhibited the invasion and metastasis of lung cancer cells, which was reversed by the further knockdown of ANXA10. In addition, the knockdown of Cul4A inhibited lung tumor metastasis in mouse tail vein injection xenograft models. Notably, Cul4A regulated the degradation of ANXA10 through its interaction with ANXA10 and ubiquitination in lung cancer cells. Our findings suggest that Cul4A is a prognostic marker in NSCLC patients, and Cul4A plays important roles in lung cancer invasion and metastasis through the regulation of the ANXA10 tumor suppressor.

17 July 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MHMing-Szu Hung
Ming-Szu Hung
YCYi-Chuan Chen
Yi-Chuan Chen
PLPaul Yann Lin
Paul Yann Lin
YLYa-Chin Li
Ya-Chin Li
CHChia-Chen Hsu
Chia-Chen Hsu
CYCheng-Ta Yang
Cheng-Ta Yang
In the original publication [...].